Ability Biotherapeutics Inc.
$360,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
EF 2025-2026
Canada
A key challenge in cancer and autoimmune disease treatment is precisely targeting diseased tissues while sparing healthy cells. The project advances antibody therapeutics to meet this challenge.